312 related articles for article (PubMed ID: 31568648)
21. Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillance.
Ha YS; Salmasi A; Karellas M; Singer EA; Kim JH; Han M; Partin AW; Kim WJ; Lee DH; Kim IY
Urology; 2013 Apr; 81(4):831-5. PubMed ID: 23465143
[TBL] [Abstract][Full Text] [Related]
22. Prostate cancer disease severity and country of origin among black men in the United States.
Fedewa SA; Jemal A
Prostate Cancer Prostatic Dis; 2013 Jun; 16(2):176-80. PubMed ID: 23338555
[TBL] [Abstract][Full Text] [Related]
23. Distinct Genomic Alterations in Prostate Tumors Derived from African American Men.
Liu W; Zheng SL; Na R; Wei L; Sun J; Gallagher J; Wei J; Resurreccion WK; Ernst S; Sfanos KS; Isaacs WB; Xu J
Mol Cancer Res; 2020 Dec; 18(12):1815-1824. PubMed ID: 33115829
[TBL] [Abstract][Full Text] [Related]
24. Development and Psychometric Properties of a Prostate Cancer Knowledge Scale for African American Men.
Owens OL; Tavakoli AS; Rose T; Wooten NR
Am J Mens Health; 2019; 13(6):1557988319892459. PubMed ID: 31849259
[TBL] [Abstract][Full Text] [Related]
25. Association between Plasma 25-Hydroxyvitamin D, Ancestry and Aggressive Prostate Cancer among African Americans and European Americans in PCaP.
Steck SE; Arab L; Zhang H; Bensen JT; Fontham ET; Johnson CS; Mohler JL; Smith GJ; Su JL; Trump DL; Woloszynska-Read A
PLoS One; 2015; 10(4):e0125151. PubMed ID: 25919866
[TBL] [Abstract][Full Text] [Related]
26. Results from a prostate cancer admixture mapping study in African-American men.
Bock CH; Schwartz AG; Ruterbusch JJ; Levin AM; Neslund-Dudas C; Land SJ; Wenzlaff AS; Reich D; McKeigue P; Chen W; Heath EI; Powell IJ; Kittles RA; Rybicki BA
Hum Genet; 2009 Nov; 126(5):637-42. PubMed ID: 19568772
[TBL] [Abstract][Full Text] [Related]
27. Prostatic compensation of the vitamin D axis in African American men.
Richards Z; Batai K; Farhat R; Shah E; Makowski A; Gann PH; Kittles R; Nonn L
JCI Insight; 2017 Jan; 2(2):e91054. PubMed ID: 28138564
[No Abstract] [Full Text] [Related]
28. The significance of anterior prostate lesions on multiparametric magnetic resonance imaging in African-American men.
Kongnyuy M; Sidana A; George AK; Muthigi A; Iyer A; Fascelli M; Kadakia M; Frye TP; Ho R; Mertan F; Minhaj Siddiqui M; Su D; Merino MJ; Turkbey B; Choyke PL; Wood BJ; Pinto PA
Urol Oncol; 2016 Jun; 34(6):254.e15-21. PubMed ID: 26905304
[TBL] [Abstract][Full Text] [Related]
29. Self-reported Black race predicts significant prostate cancer independent of clinical setting and clinical and socioeconomic risk factors.
Nettey OS; Walker AJ; Keeter MK; Singal A; Nugooru A; Martin IK; Ruden M; Gogana P; Dixon MA; Osuma T; Hollowell CMP; Sharifi R; Sekosan M; Yang X; Catalona WJ; Kajdacsy-Balla A; Macias V; Kittles RA; Murphy AB
Urol Oncol; 2018 Nov; 36(11):501.e1-501.e8. PubMed ID: 30236853
[TBL] [Abstract][Full Text] [Related]
30. Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men.
Koochekpour S; Marlowe T; Singh KK; Attwood K; Chandra D
PLoS One; 2013; 8(9):e74688. PubMed ID: 24086362
[TBL] [Abstract][Full Text] [Related]
31. The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer.
Castro E; Mikropoulos C; Bancroft EK; Dadaev T; Goh C; Taylor N; Saunders E; Borley N; Keating D; Page EC; Saya S; Hazell S; Livni N; deSouza N; Neal D; Hamdy FC; Kumar P; Antoniou AC; Kote-Jarai Z; ; Eeles RA
Oncologist; 2016 Jun; 21(6):716-22. PubMed ID: 27151655
[TBL] [Abstract][Full Text] [Related]
32. Admixture mapping of prostate cancer in African Americans participating in the North Carolina-Louisiana Prostate Cancer Project (PCaP).
Bensen JT; Xu Z; McKeigue PM; Smith GJ; Fontham ET; Mohler JL; Taylor JA
Prostate; 2014 Jan; 74(1):1-9. PubMed ID: 24037755
[TBL] [Abstract][Full Text] [Related]
33. A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer.
Cullen J; Rosner IL; Brand TC; Zhang N; Tsiatis AC; Moncur J; Ali A; Chen Y; Knezevic D; Maddala T; Lawrence HJ; Febbo PG; Srivastava S; Sesterhenn IA; McLeod DG
Eur Urol; 2015 Jul; 68(1):123-31. PubMed ID: 25465337
[TBL] [Abstract][Full Text] [Related]
34. A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history.
Kittles RA; Baffoe-Bonnie AB; Moses TY; Robbins CM; Ahaghotu C; Huusko P; Pettaway C; Vijayakumar S; Bennett J; Hoke G; Mason T; Weinrich S; Trent JM; Collins FS; Mousses S; Bailey-Wilson J; Furbert-Harris P; Dunston G; Powell IJ; Carpten JD
J Med Genet; 2006 Jun; 43(6):507-11. PubMed ID: 16155194
[TBL] [Abstract][Full Text] [Related]
35. It takes two to talk about prostate cancer: a qualitative assessment of African American men's and women's cancer communication practices and recommendations.
Friedman DB; Thomas TL; Owens OL; Hébert JR
Am J Mens Health; 2012 Nov; 6(6):472-84. PubMed ID: 22806569
[TBL] [Abstract][Full Text] [Related]
36. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics.
Jalloh M; Myers F; Cowan JE; Carroll PR; Cooperberg MR
Eur Urol; 2015 Mar; 67(3):451-7. PubMed ID: 24746973
[TBL] [Abstract][Full Text] [Related]
37. Stroke in Indigenous Africans, African Americans, and European Americans: Interplay of Racial and Geographic Factors.
Owolabi M; Sarfo F; Howard VJ; Irvin MR; Gebregziabher M; Akinyemi R; Bennett A; Armstrong K; Tiwari HK; Akpalu A; Wahab KW; Owolabi L; Fawale B; Komolafe M; Obiako R; Adebayo P; Manly JM; Ogbole G; Melikam E; Laryea R; Saulson R; Jenkins C; Arnett DK; Lackland DT; Ovbiagele B; Howard G;
Stroke; 2017 May; 48(5):1169-1175. PubMed ID: 28389611
[TBL] [Abstract][Full Text] [Related]
38. African-American men with low-grade prostate cancer have higher tumor burdens: results from the Duke Prostate Center.
Tsivian M; Bañez LL; Keto CJ; Abern MR; Qi P; Gerber L; Moul JW; Polascik TJ
Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):91-4. PubMed ID: 23032361
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of Annexin 2, SPINK1, and Hsp60 predict progression of prostate cancer through bifurcated WHO Gleason score categories in African American men.
Beyene DA; Naab TJ; Kanarek NF; Apprey V; Esnakula A; Khan FA; Blackman MR; Brown CA; Hudson TS
Prostate; 2018 Aug; 78(11):801-811. PubMed ID: 29682763
[TBL] [Abstract][Full Text] [Related]
40. Investigating racial differences in clinical and pathological features of prostate cancer in South African men.
Dewar M; Kaestner L; Zikhali Q; Jehle K; Sinha S; Lazarus J
S Afr J Surg; 2018 Jun; 56(2):54-58. PubMed ID: 30010267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
